Tezspire™ (tezepelumab injection) now available in Ca

/CNW/ - Today, AstraZeneca and Amgen announced the Canadian availability of Tezspire™ (tezepelumab injection), indicated for the add-on maintenance treatment...

Related Keywords

Canada , Japan , Canadians , Canadian , Lymphopoietin Isoforms , Anne Ellis , Mary Anne Cedrone , Daniel Martinez , Astrazeneca Canada Inc , Amgen , Canadian Society Of Allergy , Professor Of Medicine At Queen University , World Allergy Organization , Astrazeneca , Allergy Immunology Department , Global Asthma Network , Health Canada , A Canadian Thoracic Society , Airways Of Human Asthmatics In Vivo , Immunology Department , Canadian Society , Kiersten Combs , Executive Medical Director , New England Journal , Rare Disease , Amgen Canada , Canadian Product , Stromal Lymphopoietin Isoforms , Inflammatory Disorders , Human Asthmatics In Vivo , Potential Biomarker , Severe Refractory , Moderate To Severe Uncontrolled , Global Asthma , Global Asthma Report , Asthma Facts , Canadian Thoracic Society , Critical Care , Possible Explanation , Explor Res Hypothesis , Allergy Asthma , Illness Among Patients , Severe Asthma , Managed Care , Care Respir , Allergy Organization , Zeneca Canada , Astrazeneca Canada ,